GetTopicDetailResponse(id=4b13123586b8, topicName=c-Met 蛋白過表達, introduction=, content=非小細胞肺癌 奧希替尼 c-Met 蛋白過表達, image=null, comments=0, allHits=333, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Wed Jan 22 11:36:19 CST 2025, time=2025-01-22, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=500765, tagList=[TagDto(tagId=500765, tagName=c-Met 蛋白過表達)], ipAttribution=陜西省, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2249181, encodeId=78572249181b4, content=<a href='/topic/show?id=32af9938ec6' target=_blank style='color:#2F92EE;'>#非小細胞肺癌#</a> <a href='/topic/show?id=b0054454337' target=_blank style='color:#2F92EE;'>#奧希替尼#</a> <a href='/topic/show?id=4b13123586b8' target=_blank style='color:#2F92EE;'>#c-Met 蛋白過表達#</a>, objectTitle=Ann. Oncol | 突破奧希替尼耐藥瓶頸：Teliso-V聯(lián)合治療在EGFR突變型NSCLC中的新希望, objectType=article, longId=860538, objectId=491286053891, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240731/1722406154575_8538692.png, objectUrl=/article/show_article.do?id=491286053891, replyNumber=0, likeNumber=39, createdTime=2025-01-22, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=491286053891, moduleTitle=Ann. Oncol | 突破奧希替尼耐藥瓶頸：Teliso-V聯(lián)合治療在EGFR突變型NSCLC中的新希望, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=491286053891)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-01-22發(fā)表于陜西省
